nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—MTNR1A—forebrain—attention deficit hyperactivity disorder	0.0236	0.384	CbGeAlD
Ramelteon—MTNR1A—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0207	0.0221	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0207	0.0221	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.0139	0.0148	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.0139	0.0148	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0129	0.0138	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0129	0.0138	CbGpPWpGaD
Ramelteon—MTNR1A—nervous system—attention deficit hyperactivity disorder	0.0128	0.209	CbGeAlD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0126	0.0135	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.0126	0.0135	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0126	0.0134	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.0126	0.0134	CbGpPWpGaD
Ramelteon—MTNR1A—central nervous system—attention deficit hyperactivity disorder	0.0123	0.201	CbGeAlD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0111	0.0118	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.0111	0.0118	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.0109	0.0116	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.0109	0.0116	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0108	0.0115	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.0108	0.0115	CbGpPWpGaD
Ramelteon—MTNR1A—brain—attention deficit hyperactivity disorder	0.0098	0.159	CbGeAlD
Ramelteon—MTNR1A—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00945	0.0101	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00945	0.0101	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00877	0.00934	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00877	0.00934	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.0087	0.00927	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—SLC6A4—attention deficit hyperactivity disorder	0.0087	0.00927	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.0087	0.00927	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.0087	0.00927	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00842	0.00898	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.00842	0.00898	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00842	0.00897	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00842	0.00897	CbGpPWpGaD
Ramelteon—CYP1A2—Methylation—COMT—attention deficit hyperactivity disorder	0.00826	0.0088	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00826	0.0088	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00826	0.0088	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00825	0.00879	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00825	0.00879	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00818	0.00871	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.00818	0.00871	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00766	0.00816	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00766	0.00816	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00762	0.00812	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00762	0.00812	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00751	0.008	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00751	0.008	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00743	0.00792	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00743	0.00792	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00731	0.00779	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00731	0.00779	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00722	0.00769	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00722	0.00769	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00712	0.00759	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00712	0.00759	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0071	0.00756	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.0071	0.00756	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0069	0.00735	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.0069	0.00735	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00678	0.00723	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00678	0.00723	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00672	0.00716	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00672	0.00716	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0067	0.00714	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0067	0.00714	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00656	0.00699	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00656	0.00699	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00644	0.00687	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00644	0.00687	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00624	0.00665	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00624	0.00665	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0061	0.0065	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0061	0.0065	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00591	0.0063	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00591	0.0063	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00581	0.00619	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00581	0.00619	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00574	0.00611	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00574	0.00611	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00572	0.00609	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00572	0.00609	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00535	0.0057	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00535	0.0057	CbGpPWpGaD
Ramelteon—CYP1A2—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00516	0.0055	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.005	0.00533	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.005	0.00533	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00476	0.00507	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00476	0.00507	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00466	0.00497	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00466	0.00497	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00465	0.00495	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00465	0.00495	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0045	0.0048	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.0045	0.0048	CbGpPWpGaD
Ramelteon—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00449	0.00478	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00442	0.00471	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00442	0.00471	CbGpPWpGaD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00437	0.00466	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00437	0.00466	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00437	0.00466	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00437	0.00466	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00432	0.00461	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00432	0.00461	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00423	0.00451	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00423	0.00451	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00407	0.00434	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00407	0.00434	CbGpPWpGaD
Ramelteon—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00398	0.00424	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00381	0.00406	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00381	0.00406	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00374	0.00399	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00374	0.00399	CbGpPWpGaD
Ramelteon—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.0035	0.00373	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00323	0.00344	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00323	0.00344	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00297	0.00317	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00297	0.00317	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00294	0.00313	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00294	0.00313	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00285	0.00304	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00285	0.00304	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00283	0.00301	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.00283	0.00301	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00283	0.00301	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00283	0.00301	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00263	0.0028	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00263	0.0028	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00257	0.00273	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00257	0.00273	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00255	0.00272	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00255	0.00272	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00254	0.00271	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00254	0.00271	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.0025	0.00267	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.0025	0.00267	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.0025	0.00266	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.0025	0.00266	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00247	0.00263	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00247	0.00263	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00245	0.00261	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00245	0.00261	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00239	0.00254	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00239	0.00254	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00231	0.00246	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00231	0.00246	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0023	0.00245	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0023	0.00245	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00227	0.00242	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00227	0.00242	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00224	0.00239	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00224	0.00239	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00209	0.00223	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00209	0.00223	CbGpPWpGaD
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00203	0.00217	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00173	0.00185	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00173	0.00185	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00161	0.00172	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00161	0.00172	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00159	0.00169	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00152	0.00161	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00152	0.00161	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00146	0.00156	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00146	0.00156	CbGpPWpGaD
Ramelteon—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00146	0.0237	CbGeAlD
Ramelteon—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	0.00145	0.00154	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00141	0.0015	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00141	0.0015	CbGpPWpGaD
Ramelteon—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.0014	0.0228	CbGeAlD
Ramelteon—MTNR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00136	0.00145	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00136	0.00145	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00134	0.00143	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00134	0.00143	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00132	0.00141	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00132	0.00141	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00123	0.00131	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00123	0.00131	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00122	0.0013	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00109	0.00116	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00108	0.00115	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00107	0.00114	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00104	0.00111	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00104	0.00111	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000864	0.000921	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000864	0.000921	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000848	0.000904	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000842	0.000897	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000836	0.000891	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000655	0.000697	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00065	0.000693	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000646	0.000688	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000458	0.000488	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000458	0.000488	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000445	0.000474	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000347	0.00037	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000307	0.000327	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000307	0.000327	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000302	0.000322	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000281	0.000299	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000268	0.000285	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000246	0.000262	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000239	0.000255	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000239	0.000255	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000236	0.000251	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000234	0.000249	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000219	0.000233	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000191	0.000204	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000186	0.000198	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000185	0.000197	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000185	0.000197	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000185	0.000197	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000182	0.000194	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000182	0.000194	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000179	0.000191	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000169	0.00018	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000148	0.000157	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000145	0.000155	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000144	0.000153	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000141	0.00015	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00014	0.000149	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.000112	0.000119	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000111	0.000118	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	7.98e-05	8.51e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	6.22e-05	6.63e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	4.8e-05	5.11e-05	CbGpPWpGaD
